Science Explorer Interactive view Map
Research facility · Fort Worth · United States

Center for Cancer and Blood Disorders

In research, Center for Cancer and Blood Disorders stands highest in Medicine (#4,306 of 10,443 worldwide) and Health Sciences (#5,711 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Hematology, Genetics and Oncology — Hematology is 42.6× its share of world research.

World rank, 2022–2025
#9,379
of 28,054 · #10,309 all time
Rank in United States
#1,252
of 4,192
Research works
843
▲ 34% vs 2013–17
Citations
22k
26.6 per fractional work
Top-10% rate
17.7%
record average 16.5%
Open access
43%
world 28%

What is Center for Cancer and Blood Disorders known for in research?

The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorksAll time
MedicineField #4,306 of 10,443 16.0%156 #3038
Health SciencesDomain #5,711 of 11,982 16.0%164 #4047

Each strip is that field’s whole ranked pool, with the notch where Center for Cancer and Blood Disorders sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

What does Center for Cancer and Blood Disorders specialise in?

Where its research is concentrated relative to its size: Hematology takes 42.6× the share of its output that it takes of world research.

  1. HematologySubfield · 27.9 works43×
  2. GeneticsSubfield · 21.8 works37×
  3. OncologySubfield · 23.2 works9.6×
← less than its size predictsmore →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 2.30× its world share, 26 worksBiochemistry, Geneti…Immunology and Microbiology: 5.52× its world share, 12 worksImmunology and Micro…Neuroscience: 0.45× its world share, 2 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 0.56× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.17× its world share, 1 worksChemistryComputer Science: 0.02× its world share, 0 worksComputer ScienceEngineering: 0.10× its world share, 3 worksEngineeringEnvironmental Science: 0.02× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.03× its world share, 0 worksMaterials ScienceMathematics: 0.01× its world share, 0 worksMathematicsPhysics and Astronomy: 0.06× its world share, 0 worksPhysics and AstronomyDentistry: 0.04× its world share, 0 worksDentistryHealth Professions: 1.19× its world share, 7 worksHealth ProfessionsMedicine: 3.77× its world share, 156 worksMedicineNursing: 0.52× its world share, 1 worksNursingArts and Humanities: 0.02× its world share, 0 worksArts and HumanitiesBusiness, Management and Accounting: 0.08× its world share, 1 worksBusiness, Management…Decision Sciences: 0.01× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.25× its world share, 1 worksEconomics, Econometr…Psychology: 0.34× its world share, 2 worksPsychologySocial Sciences: 0.10× its world share, 3 worksSocial Sciencesworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Immunology and Microbiology, 5.5×. Every wedge is a field page.

Who are the top researchers at Center for Cancer and Blood Disorders?

Ranked on the composite score, Ray D. Page, Ralph V. Boccia and Sue P. Heiney lead among researchers whose main affiliation is Center for Cancer and Blood Disorders.

  1. 1 Ray D. Page United States · #451,277 worldwide 57 citations · 26 works
  2. 2 Ralph V. Boccia United States · #1,192,306 worldwide 21 citations · 27 works
  3. 3 Sue P. Heiney United States · #1,203,136 worldwide 26 citations · 24 works
All ranked researchers at Center for Cancer and Blood Disorders

Which keywords describe research at Center for Cancer and Blood Disorders?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Prognostic Factors, Immunotherapy, Lymphoma, Pulmonary Hypertension, Sickle-cell Disease, Thalassemia, Hematopoietic Stem Cells and Cancer Immunotherapy.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Prognostic Factors22▲ 23×13 topics
  2. Immunotherapy21▲ 14×14 topics
  3. Epidemiology19▲ 2.2×42 topics
  4. Lymphoma15▲ 44×3 topics
  5. Pulmonary Hypertension13▲ 43×3 topics
  6. Inflammation13▲ 2.9×34 topics
  7. Sickle-cell Disease13▲ 138×1 topic
  8. Thalassemia13▲ 138×1 topic
  9. Hematopoietic Stem Cells12▲ 64×3 topics
  10. Chemotherapy11▲ 7.5×21 topics
  11. Cancer Immunotherapy11▲ 34×3 topics
  12. Leukemia11▲ 59×2 topics
  13. Cancer10▲ 3.6×28 topics
  14. Tumor Regression10▲ 44×2 topics
  15. Health-related Quality of Life10▲ 20×4 topics
  16. Genetic Mutations10▲ 11×14 topics
  17. CAR T Cells10▲ 63×1 topic
  18. Chimeric Antigen Receptor10▲ 63×1 topic
  19. Anemia9▲ 45×4 topics
  20. Childhood Cancer Survivor Study9▲ 91×1 topic
  21. Pediatric Quality of Life Inventory9▲ 91×1 topic
  22. Minimal Residual Disease8▲ 58×2 topics
  23. Rituximab8▲ 23×2 topics
  24. Acute Lymphoblastic Leukemia7▲ 100×1 topic
  25. Childhood Cancer7▲ 100×1 topic
  26. AML7▲ 63×1 topic
  27. Acute Myeloid Leukemia7▲ 63×1 topic
  28. Radiotherapy6▲ 7.7×11 topics
  29. Erythropoiesis6▲ 45×2 topics
  30. Iron Deficiency6▲ 51×2 topics
  31. Staging System6▲ 42×2 topics
  32. PET Imaging6▲ 15×4 topics
  33. Classification5▲ 5.5×4 topics
  34. Prognosis5▲ 7.1×6 topics
  35. Gene Expression Profiling5▲ 27×2 topics
  36. Molecular Profiling5▲ 22×2 topics
  37. Genetic Pathogenesis5▲ 41×1 topic
  38. Hodgkin's Lymphoma5▲ 41×1 topic
  39. Hepcidin5▲ 55×1 topic
  40. Iron Regulation5▲ 55×1 topic

Which research topics does Center for Cancer and Blood Disorders publish most on?

By volume in 2022–2025: Hemoglobinopathies and Related Disorders, CAR-T cell therapy research, Childhood Cancer Survivors' Quality of Life and Acute Lymphoblastic Leukemia research.

  1. 1 Hemoglobinopathies and Related Disorders Genetics 13 works
  2. 2 CAR-T cell therapy research Oncology 10 works
  3. 3 Childhood Cancer Survivors' Quality of Life Pediatrics, Perinatology and Child Health 9 works
  4. 4 Acute Lymphoblastic Leukemia research Public Health, Environmental and Occupational Health 7 works
  5. 5 Acute Myeloid Leukemia Research Hematology 7 works
  6. 6 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 5 works
  7. 7 Iron Metabolism and Disorders Hematology 5 works
  8. 8 Hematopoietic Stem Cell Transplantation Hematology 4 works
  9. 9 Neuroblastoma Research and Treatments Neurology 4 works
  10. 10 Glioma Diagnosis and Treatment Genetics 4 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available42.8%not open57.2%

World: 28% of research is openly available.

with international co-authors18.1%domestic only81.9%

World: 19% is written across borders.

How has Center for Cancer and Blood Disorders's research output changed?

Output in 2018–2022 was 34% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Fort Worth

All research institutions in Fort Worth

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.